[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Visceral Pain Treatment Market Report 2018

January 2018 | 100 pages | ID: UD526D37831EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Visceral Pain Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Visceral Pain Treatment in these regions, from 2013 to 2025 (forecast).
United States Visceral Pain Treatment market competition by top manufacturers/players, with Visceral Pain Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Addex Therapeutics Ltd
  • Astellas Pharma Inc.
  • Chromocell Corporation
  • GIcare Pharma Inc
  • Grunenthal GmbH
  • Medestea Research & Production S.p.A.
  • Neurim Pharmaceuticals Ltd
  • Pfizer Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • HS-665
  • CC-8464
  • BLU-5937
  • APD-371
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • In-patient
  • Out-patient
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Visceral Pain Treatment Market Report 2018

1 VISCERAL PAIN TREATMENT OVERVIEW

1.1 Product Overview and Scope of Visceral Pain Treatment
1.2 Classification of Visceral Pain Treatment by Product Category
  1.2.1 United States Visceral Pain Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Visceral Pain Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 HS-665
  1.2.4 CC-8464
  1.2.5 BLU-5937
  1.2.6 APD-371
  1.2.7 Others
1.3 United States Visceral Pain Treatment Market by Application/End Users
  1.3.1 United States Visceral Pain Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 In-patient
  1.3.3 Out-patient
1.4 United States Visceral Pain Treatment Market by Region
  1.4.1 United States Visceral Pain Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Visceral Pain Treatment Status and Prospect (2013-2025)
  1.4.3 Southwest Visceral Pain Treatment Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Visceral Pain Treatment Status and Prospect (2013-2025)
  1.4.5 New England Visceral Pain Treatment Status and Prospect (2013-2025)
  1.4.6 The South Visceral Pain Treatment Status and Prospect (2013-2025)
  1.4.7 The Midwest Visceral Pain Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Visceral Pain Treatment (2013-2025)
  1.5.1 United States Visceral Pain Treatment Sales and Growth Rate (2013-2025)
  1.5.2 United States Visceral Pain Treatment Revenue and Growth Rate (2013-2025)

2 UNITED STATES VISCERAL PAIN TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Visceral Pain Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Visceral Pain Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Visceral Pain Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Visceral Pain Treatment Market Competitive Situation and Trends
  2.4.1 United States Visceral Pain Treatment Market Concentration Rate
  2.4.2 United States Visceral Pain Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Visceral Pain Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VISCERAL PAIN TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Visceral Pain Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Visceral Pain Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Visceral Pain Treatment Price by Region (2013-2018)

4 UNITED STATES VISCERAL PAIN TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Visceral Pain Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Visceral Pain Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Visceral Pain Treatment Price by Type (2013-2018)
4.4 United States Visceral Pain Treatment Sales Growth Rate by Type (2013-2018)

5 UNITED STATES VISCERAL PAIN TREATMENT SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Visceral Pain Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Visceral Pain Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES VISCERAL PAIN TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Addex Therapeutics Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Visceral Pain Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Astellas Pharma Inc.
  6.2.2 Visceral Pain Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Astellas Pharma Inc. Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Chromocell Corporation
  6.3.2 Visceral Pain Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Chromocell Corporation Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GIcare Pharma Inc
  6.4.2 Visceral Pain Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GIcare Pharma Inc Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Grunenthal GmbH
  6.5.2 Visceral Pain Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Grunenthal GmbH Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Medestea Research & Production S.p.A.
  6.6.2 Visceral Pain Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Neurim Pharmaceuticals Ltd
  6.7.2 Visceral Pain Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Pfizer Inc.
  6.8.2 Visceral Pain Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Inc. Visceral Pain Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 VISCERAL PAIN TREATMENT MANUFACTURING COST ANALYSIS

7.1 Visceral Pain Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Visceral Pain Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Visceral Pain Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Visceral Pain Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VISCERAL PAIN TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Visceral Pain Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Visceral Pain Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Visceral Pain Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Visceral Pain Treatment Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Visceral Pain Treatment
Figure United States Visceral Pain Treatment Market Size (K Pcs) by Type (2013-2025)
Figure United States Visceral Pain Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure HS-665 Product Picture
Figure CC-8464 Product Picture
Figure BLU-5937 Product Picture
Figure APD-371 Product Picture
Figure Others Product Picture
Figure United States Visceral Pain Treatment Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Visceral Pain Treatment by Application in 2017
Figure In-patient Examples
Table Key Downstream Customer in In-patient
Figure Out-patient Examples
Table Key Downstream Customer in Out-patient
Figure United States Visceral Pain Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Visceral Pain Treatment Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Visceral Pain Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Visceral Pain Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Visceral Pain Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Visceral Pain Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Visceral Pain Treatment Sales Share by Players/Suppliers
Figure 2017 United States Visceral Pain Treatment Sales Share by Players/Suppliers
Figure United States Visceral Pain Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Visceral Pain Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Visceral Pain Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Visceral Pain Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Visceral Pain Treatment Revenue Share by Players/Suppliers
Table United States Market Visceral Pain Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Visceral Pain Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Visceral Pain Treatment Market Share of Top 3 Players/Suppliers
Figure United States Visceral Pain Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Visceral Pain Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Visceral Pain Treatment Product Category
Table United States Visceral Pain Treatment Sales (K Pcs) by Region (2013-2018)
Table United States Visceral Pain Treatment Sales Share by Region (2013-2018)
Figure United States Visceral Pain Treatment Sales Share by Region (2013-2018)
Figure United States Visceral Pain Treatment Sales Market Share by Region in 2017
Table United States Visceral Pain Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Visceral Pain Treatment Revenue Share by Region (2013-2018)
Figure United States Visceral Pain Treatment Revenue Market Share by Region (2013-2018)
Figure United States Visceral Pain Treatment Revenue Market Share by Region in 2017
Table United States Visceral Pain Treatment Price (USD/Pcs) by Region (2013-2018)
Table United States Visceral Pain Treatment Sales (K Pcs) by Type (2013-2018)
Table United States Visceral Pain Treatment Sales Share by Type (2013-2018)
Figure United States Visceral Pain Treatment Sales Share by Type (2013-2018)
Figure United States Visceral Pain Treatment Sales Market Share by Type in 2017
Table United States Visceral Pain Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Visceral Pain Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Visceral Pain Treatment by Type (2013-2018)
Figure Revenue Market Share of Visceral Pain Treatment by Type in 2017
Table United States Visceral Pain Treatment Price (USD/Pcs) by Types (2013-2018)
Figure United States Visceral Pain Treatment Sales Growth Rate by Type (2013-2018)
Table United States Visceral Pain Treatment Sales (K Pcs) by Application (2013-2018)
Table United States Visceral Pain Treatment Sales Market Share by Application (2013-2018)
Figure United States Visceral Pain Treatment Sales Market Share by Application (2013-2018)
Figure United States Visceral Pain Treatment Sales Market Share by Application in 2017
Table United States Visceral Pain Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Visceral Pain Treatment Sales Growth Rate by Application (2013-2018)
Table Addex Therapeutics Ltd Basic Information List
Table Addex Therapeutics Ltd Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Addex Therapeutics Ltd Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Addex Therapeutics Ltd Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Addex Therapeutics Ltd Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Astellas Pharma Inc. Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Chromocell Corporation Basic Information List
Table Chromocell Corporation Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Chromocell Corporation Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Chromocell Corporation Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Chromocell Corporation Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table GIcare Pharma Inc Basic Information List
Table GIcare Pharma Inc Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GIcare Pharma Inc Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure GIcare Pharma Inc Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure GIcare Pharma Inc Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Grunenthal GmbH Basic Information List
Table Grunenthal GmbH Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Grunenthal GmbH Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Grunenthal GmbH Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Grunenthal GmbH Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Medestea Research & Production S.p.A. Basic Information List
Table Medestea Research & Production S.p.A. Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Medestea Research & Production S.p.A. Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Medestea Research & Production S.p.A. Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Medestea Research & Production S.p.A. Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Neurim Pharmaceuticals Ltd Basic Information List
Table Neurim Pharmaceuticals Ltd Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Neurim Pharmaceuticals Ltd Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Neurim Pharmaceuticals Ltd Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Neurim Pharmaceuticals Ltd Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Visceral Pain Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Inc. Visceral Pain Treatment Sales Growth Rate (2013-2018)
Figure Pfizer Inc. Visceral Pain Treatment Sales Market Share in United States (2013-2018)
Figure Pfizer Inc. Visceral Pain Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Visceral Pain Treatment
Figure Manufacturing Process Analysis of Visceral Pain Treatment
Figure Visceral Pain Treatment Industrial Chain Analysis
Table Raw Materials Sources of Visceral Pain Treatment Major Players/Suppliers in 2017
Table Major Buyers of Visceral Pain Treatment
Table Distributors/Traders List
Figure United States Visceral Pain Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Visceral Pain Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Visceral Pain Treatment Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Visceral Pain Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Visceral Pain Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Visceral Pain Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications